Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1

NCT05520970 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Study early terminated based on the sponsor(manufacture)'s decision

Conditions

COVID-19
Vaccines

Interventions

BIOLOGICAL: AdCLD-CoV19-1

Sponsor

Cellid Co., Ltd.

Collaborators

[object Object]